fda shortage semaglutide injection resolved feb 21 2025 status january As of February 21, 2025, the updated its drug list Wegovy Shortage Resolved: 2026 Availability

Weight loss being a reported side effect of Ozempic helped pave the way for other GLP-1 medications, like Wegovy , that are specifically FDA-approved for weight loss

According to altRx, the full process from completing the eligibility evaluation to receiving medication typically takes approximately 2 to 3 weeks

Survodutide is developed by Boehringer Ingelheim with Phase 3 trials currently underway

Higher scores indicate fewer symptoms and physical limitations and weight change from baseline

Thats why its important to only use reputable compounding pharmacies and follow the guidance of a trusted healthcare provider

Wegovy contains semaglutide